NovaBridge Biosciences (NBP)
1.02
-0.05
(-4.67%)
USD |
NASDAQ |
Nov 03, 13:24
NovaBridge Biosciences Price : 1.02 for Nov. 3, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 02, 2026 | 1.21 | 1.21 | 1.06 | 1.07 | 1.068M |
| Oct 30, 2026 | 1.21 | 1.228 | 1.15 | 1.195 | 583225.0 |
| Oct 29, 2026 | 1.26 | 1.280 | 1.195 | 1.21 | 363882.0 |
| Oct 28, 2026 | 1.25 | 1.26 | 1.19 | 1.26 | 268090.0 |
| Oct 27, 2026 | 1.22 | 1.308 | 1.22 | 1.255 | 437986.0 |
| Oct 26, 2026 | 1.39 | 1.39 | 1.21 | 1.215 | 828469.0 |
| Oct 23, 2026 | 1.31 | 1.379 | 1.26 | 1.37 | 558749.0 |
| Oct 22, 2026 | 1.34 | 1.360 | 1.255 | 1.33 | 456188.0 |
| Oct 21, 2026 | 1.43 | 1.43 | 1.34 | 1.37 | 586869.0 |
| Oct 20, 2026 | 1.30 | 1.46 | 1.300 | 1.425 | 657976.0 |
| Oct 19, 2026 | 1.27 | 1.345 | 1.27 | 1.30 | 662059.0 |
| Oct 16, 2026 | 1.30 | 1.31 | 1.26 | 1.26 | 350688.0 |
| Oct 15, 2026 | 1.29 | 1.32 | 1.29 | 1.29 | 390687.0 |
| Oct 14, 2026 | 1.28 | 1.30 | 1.26 | 1.28 | 427815.0 |
| Oct 13, 2026 | 1.33 | 1.335 | 1.26 | 1.29 | 711696.0 |
| Oct 12, 2026 | 1.40 | 1.40 | 1.31 | 1.32 | 274060.0 |
| Oct 09, 2026 | 1.38 | 1.419 | 1.37 | 1.395 | 295924.0 |
| Oct 08, 2026 | 1.37 | 1.38 | 1.34 | 1.37 | 250099.0 |
| Oct 07, 2026 | 1.40 | 1.41 | 1.37 | 1.37 | 353902.0 |
| Oct 06, 2026 | 1.38 | 1.44 | 1.38 | 1.40 | 379837.0 |
| Oct 05, 2026 | 1.37 | 1.385 | 1.35 | 1.36 | 184989.0 |
| Oct 02, 2026 | 1.34 | 1.36 | 1.33 | 1.355 | 252911.0 |
| Oct 01, 2026 | 1.36 | 1.39 | 1.31 | 1.34 | 342369.0 |
| Sep 30, 2026 | 1.38 | 1.40 | 1.35 | 1.365 | 250299.0 |
| Sep 29, 2026 | 1.38 | 1.41 | 1.35 | 1.37 | 294569.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Xencor, Inc. | 30.86 |
| Arrivent BioPharma, Inc. | 13.33 |
| ACADIA Pharmaceuticals, Inc. | 20.76 |
| Alnylam Pharmaceuticals, Inc. | 159.66 |
| Anika Therapeutics, Inc. | 19.27 |
Price Related Metrics
| Market Cap | 118.32M |